Submitted:
12 June 2026
Posted:
15 June 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Patients
2.2. Histopathological Quality Assessment
2.3. Anesthesia and Surgical Technique
2.4. Statistical Analysis
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bray, F.; Laversanne, M.; Sung, H.; Ferlay, J.; Siegel, R.L.; Soerjomataram, I.; Jemal, A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2024, 74, 229–263. [Google Scholar] [CrossRef] [PubMed]
- Compérat, E.; Larré, S.; Roupret, M.; Neuzillet, Y.; Pignot, G.; Quintens, H.; Houéde, N.; Roy, C.; Durand, X.; Varinot, J.; et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch. 2015, 466, 589–594. [Google Scholar] [CrossRef]
- Babjuk, M.; Burger, M.; Capoun, O.; Cohen, D.; Compérat, E.M.; Dominguez Escrig, J.L.; Gontero, P.; Liedberg, F.; Masson-Lecomte, A.; Mostafid, A.H.; et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur. Urol. 2022, 81, 75–94. [Google Scholar] [CrossRef] [PubMed]
- Mariappan, P.; Zachou, A.; Grigor, K.M.; Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur. Urol. 2010, 57, 843–849. [Google Scholar] [CrossRef]
- Shoshany, O.; Mano, R.; Margel, D.; Baniel, J.; Yossepowitch, O. Presence of detrusor muscle in bladder tumor specimens—predictors and effect on outcome as a measure of resection quality. Urol. Oncol. 2014, 32, 40.e17–40.e22. [Google Scholar] [CrossRef]
- Mariappan, P.; Finney, S.M.; Head, E.; Somani, B.K.; Zachou, A.; Smith, G.; Mishriki, S.F.; N'Dow, J.; Grigor, K.M.; Edinburgh Urological Cancer Group. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer. BJU Int. 2012, 109, 1666–1673. [Google Scholar] [CrossRef]
- Brierley, J.D.; Gospodarowicz, M.K.; Wittekind, C. (Eds.) TNM Classification of Malignant Tumours, 8th ed.; Wiley-Blackwell: Oxford, UK, 2017. [Google Scholar]
- Mariappan, P.; Johnston, A.; Padovani, L.; Clark, E.; Trail, M.; Hamid, S.; Hollins, G.; Simpson, H.; Thomas, B.G.; Hasan, R.; et al. Enhanced quality and effectiveness of transurethral resection of bladder tumour in non-muscle-invasive bladder cancer: a multicentre real-world experience from Scotland's Quality Performance Indicators Programme. Eur. Urol. 2020, 78, 520–530. [Google Scholar] [CrossRef]
- Rouprêt, M.; Yates, D.R.; Varinot, J.; Phé, V.; Chartier-Kastler, E.; Bitker, M.O.; Compérat, E. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience. Can. J. Urol. 2012, 19, 6459–6464. [Google Scholar] [PubMed]
- Panagoda, P.I.; Vasdev, N.; Gowrie-Mohan, S. Avoiding the obturator jerk during TURBT. Curr. Urol. 2018, 12, 1–5. [Google Scholar] [CrossRef]
- Freisburger, C.; Nachtigall, B.; Wulf, H. Obturator nerve block: techniques and indications. Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 2010, 45, 314–315. [Google Scholar] [CrossRef]
- García Rodríguez, J.; Jalón Monzón, A.; González Alvarez, R.C.; Ardura Laso, C.; Fernández Gomez, J.M.; Rodríguez Martinez, J.J.; Martínez Gómez, F.J.; Regadera Sejas, J.; González Huergo, F. An alternative technique to prevent obturator nerve stimulation during lateral bladder tumours transurethral resection. Actas Urol. Esp. 2005, 29, 445–447. [Google Scholar] [CrossRef] [PubMed]
- Bolenz, C.; Hautmann, R.E. Surgical treatment of bladder cancer: advances made in the past 50 years. Aktuelle Urol. 2019, 50, 366–377. [Google Scholar] [CrossRef]
- Krishan, A.; Bruce, A.; Khashaba, S.; Abouelela, M.; Ehsanullah, S.A. Safety and efficacy of transurethral resection of bladder tumor comparing spinal anesthesia with spinal anesthesia with an obturator nerve block: a systematic review and meta-analysis. J. Endourol. 2021, 35, 249–258. [Google Scholar] [CrossRef]
- Alavi, C.E.; Asgari, S.A.; Falahatkar, S.; Rimaz, S.; Naghipour, M.; Khoshrang, H.; Jafari, M.; Herfeh, N. Effectiveness of spinal anesthesia combined with obturator nerve blockade in preventing adductor muscle contraction during transurethral resection of bladder tumor. Turk. J. Urol. 2017, 43, 507–511. [Google Scholar] [CrossRef] [PubMed]
- Tekgül, Z.T.; Divrik, R.T.; Turan, M.; Konyalioğlu, E.; Şimşek, E.; Gönüllü, M. Impact of obturator nerve block on the short-term recurrence of superficial bladder tumors on the lateral wall. Urol. J. 2014, 11, 1248–1252. [Google Scholar] [CrossRef]
- Taha, A.M. Ultrasound-guided obturator nerve block: a proximal interfascial technique. Anesth. Analg. 2012, 114, 236–239. [Google Scholar] [CrossRef] [PubMed]
- Soong, J.; Schafhalter-Zoppoth, I.; Gray, A.T. Sonographic imaging of the obturator nerve for regional block. Reg. Anesth. Pain Med. 2007, 32, 146–151. [Google Scholar] [CrossRef]
- Ong, E.L.; Chan, S.T. Transurethral surgery and the adductor spasm. Ann. Acad. Med. Singap. 2000, 29, 259–262. [Google Scholar] [CrossRef]
- Olawin, A.M.; Das, J.M. Spinal Anesthesia. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2025; Available online: https://www.ncbi.nlm.nih.gov/books/NBK537299.
- Yoshida, T.; Nakamoto, T.; Kamibayashi, T. Ultrasound-guided obturator nerve block: a focused review on anatomy and updated techniques. BioMed Res. Int. 2017, 2017, 7023750. [Google Scholar] [CrossRef]
- Hadzic, A.; NYSORA Editorial Team. Obturator Nerve Block; The New York School of Regional Anesthesia: New York, NY, USA, 2023; Available online: https://www.nysora.com/techniques/lower-extremity/obturator-nerve-block.
- Horsanali, M.O.; Eren, H.; Dil, E.; Çağlayan, A.; Erdoğan, Ö.; Karaarslan, S. The effect of obturator nerve blockade on oncological outcomes of patients with lateral wall localized non-muscle invasive bladder cancer. J. Urol. Surg. 2023, 10, 199–205. [Google Scholar] [CrossRef]
- Erbay, G.; Akyol, F.; Karabakan, M.; Celebi, B.; Keskin, E.; Hirik, E. Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the disease. Kaohsiung J. Med. Sci. 2017, 33, 86–90. [Google Scholar] [CrossRef] [PubMed]
- Kim, L.H.C.; Patel, M.I. Transurethral resection of bladder tumour (TURBT). Transl. Androl. Urol. 2020, 9, 3056–3072. [Google Scholar] [CrossRef] [PubMed]


| Quality Category | Histopathological Criteria | Diagnostic Value |
|---|---|---|
| Quality 1 (good) | Well-preserved tissue architecture; minimal or absent thermal artifacts; clear identification of the urothelial tumor, lamina propria, and presence of the detrusor muscle layer | Optimal for correct staging and grading; reliable assessment of invasion depth |
| Quality 2 (intermediate) | Moderate coagulation artifacts, with partial preservation of tissue architecture; detrusor muscle layer present but fragmented or partially masked | Acceptable for diagnosis and grading; limitations in precise assessment of invasion |
| Quality 3 (poor) | Extensive thermal artifacts, tissue fragmentation, or charring; absence of the detrusor muscle layer | Reduced diagnostic value; increased risk of pathological understaging and need for re-resection |
| Parameter | Total (%) | ONB | non-ONB | p-Value |
|---|---|---|---|---|
| No. of cases | 219 (100.0%) | 135 (61.6%) | 84 (38.4%) | |
| Age, years | 73 (66–75) | 73 (68–75) | 72 (65.75–75) | 0.220 b |
| BMI, kg/m² | 26.57 (24.22–29.41) | 26.64 (24.22–29.41) | 26.39 (24.22–29.49) | 0.999 b |
| Sex (%) | 0.330 a | |||
| Male | 173 (79.0%) | 110 (81.5%) | 63 (75.0%) | |
| Female | 46 (21.0%) | 25 (18.5%) | 21 (25.0%) | |
| Smoking status | 72 (32.9%) | 47 (34.8%) | 25 (29.8%) | 0.531 a |
| Alcohol consumption | 137 (62.6%) | 88 (65.2%) | 49 (58.3%) | 0.381 a |
| Tumor size (%) | 0.318 a | |||
| ≤3 cm | 195 (89.0%) | 122 (90.4%) | 73 (86.9%) | |
| >3 cm | 24 (11.0%) | 13 (9.6%) | 11 (13.1%) | |
| Tumor grade (%) | 0.892 a | |||
| G1 | 52 (23.7%) | 32 (23.7%) | 20 (23.8%) | |
| G2 | 69 (31.5%) | 43 (31.9%) | 26 (31.0%) | |
| G3 | 98 (44.8%) | 60 (44.4%) | 38 (45.2%) | |
| Tumor stage (%) | 0.981 a | |||
| Ta | 78 (35.6%) | 48 (35.6%) | 30 (35.7%) | |
| T1 | 141 (64.4%) | 87 (64.4%) | 54 (64.3%) | |
| Histopathological quality of resection specimen (%) | <0.001 a,* | |||
| Quality 1 | 126 (57.5%) | 96 (71.1%) | 30 (35.7%) | |
| Quality 2 | 63 (28.8%) | 28 (20.7%) | 35 (41.7%) | |
| Quality 3 | 30 (13.7%) | 11 (8.1%) | 19 (22.6%) | |
| Complications (%) | ||||
| Perforation | 5 (2.3%) | 0 (0.0%) | 5 (6.0%) | 0.008 c,* |
| Hematuria | 39 (17.8%) | 15 (11.1%) | 24 (28.6%) | 0.002 a,* |
| Urinary tract infection | 16 (7.3%) | 6 (4.4%) | 10 (11.9%) | 0.073 a |
| Follow-up (%) | ||||
| 12-month recurrence | 20 (9.1%) | 6 (4.4%) | 14 (16.7%) | 0.005 a,* |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).